BULERIA. Repositorio Institucional de la Universidad de León
Publication
Artículo científico (JournalArticle)
Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum, Venenos de la Topoisomerasa IB inducen la fosforilación de la histona H2A como respuesta al daño del ADN en Leishmania infantum
[EN] DNA topoisomerases are considered consolidated druggable targets against diseases produced by trypanosomatids. Several reports indicated that indenoisoquinolines, a family of non-camptothecinic based topoisomerase poisons, have a strong leishmanicidal effect both in vitro and in vivo in murine models of visceral leishmaniasis. The antileishmanial effect of the indenoisoquinolines implies several mechanisms that include the stabilization of the cleavage complex, histone H2A phosphorylation and DNA fragmentation. A series of 20 compounds with the indenoisoquinoline scaffold and several substituents at positions N6, C3, C8 and C9, were tested both in promastigotes and in intramacrophage splenic amastigotes obtained from an experimental murine infection. The antileishmanial effect of most of these compounds was within the micromolar or submicromolar range. In addition, the introduction of an N atom in the indenoisoquinoline ring (7-azaindenoisoquinolines) produced the highest selectivity index along with strong DNA topoisomerase IB inhibition, histone H2A phosphorylation and DNA-topoisomerase IB complex stabilization. This report shows for the first time the effect of a series of synthetic indenoisoquinolines on histone H2A phosphorylation, which represents a primary signal of double stranded DNA break in genus Leishmania., SI, This research was supported in part by Ministerio de Economía y Competitividad (MINECO, AEI, FEDER, UE; [MINECO: AGL2016- 79813-C2-1R and SAF2017-83575-R]), and Junta de Castilla y León cofinanced by FEDER, UE (LE020P17). CGC is supported by a scholarship of Junta de Castilla y León cofinanced by FEDER. We thank University of Leon for providing funding to cover publication expenses.